Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The H5N1 Milk Detection Study is a research trial that aims to find out if drinking pasteurized milk containing inactive pieces of the A(H5) flu virus can be detected in the nose or throat. These inactive particles cannot make you sick, and the study's results will help health experts, like those at the Centers for Disease Control and Prevention (CDC), understand how drinking milk might influence flu monitoring. Researchers also want to see if this milk consumption triggers the body to produce antibodies, which are substances that help fight infections.
To participate in this study, you need to be between 18 and 64 years old, in generally good health, and able to give informed consent in English. There are some restrictions, such as having no recent respiratory illnesses, not being pregnant or breastfeeding, and not having allergies to milk. If you join the study, you will have visits where researchers will check on your health and gather information. This study is not yet recruiting participants, but it’s an important step in understanding how milk and flu viruses might be linked.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18-64 years
- • BMI ≤ 35 kg/m2
- • Able to understand and give informed consent (American English) and comply with study visits and procedures.
- • In good general health based on medical history and the investigator's clinical judgment.
- Exclusion Criteria:
- • Symptoms of acute respiratory illness or conjunctivitis within 7 days
- • Febrile illness in the previous 72 hours
- • Recent influenza antiviral use (within 14 days)
- • Immunosuppression due to illness or medications
- • Current pregnancy or breastfeeding
- • History of allergy or intolerance to milk or milk alternatives
- • Consumption of raw (unpasteurized) milk within the previous 14 days
- • Recent work (within 14 days) on a farm with animals known to be infected with A(H5) virus
- • Previous receipt of A(H5) vaccine at any time
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Daniel Graciaa, MD, MPH, MSc
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported